Loring Wolcott & Coolidge Fiduciary Advisors LLP Forte Biosciences, Inc. Transaction History
Loring Wolcott & Coolidge Fiduciary Advisors LLP
- $10.5 Billion
- Q2 2024
A detailed history of Loring Wolcott & Coolidge Fiduciary Advisors LLP transactions in Forte Biosciences, Inc. stock. As of the latest transaction made, Loring Wolcott & Coolidge Fiduciary Advisors LLP holds 193 shares of FBRX stock, worth $984. This represents 0.0% of its overall portfolio holdings.
Number of Shares
193
Previous 193
-0.0%
Holding current value
$984
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding FBRX
# of Institutions
33Shares Held
19MCall Options Held
3.1KPut Options Held
0-
Tybourne Capital Management (Hk) LTD Hong Kong, K33.62MShares$18.5 Million0.49% of portfolio
-
Perceptive Advisors LLC New York, NY3.27MShares$16.7 Million0.05% of portfolio
-
Bvf Inc San Francisco, CA2.98MShares$15.2 Million0.05% of portfolio
-
Cable Car Capital LLC San Francisco, CA2.03MShares$10.4 Million1.15% of portfolio
-
Fred Alger Management, LLC New York, NY1.84MShares$9.38 Million0.0% of portfolio
About Forte Biosciences, Inc.
- Ticker FBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,340,300
- Market Cap $104M
- Description
- Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.